Proteus Approved for Wearable, Digestable Sensor Technology

Feb 01 2012

REDWOOD CITY, California—Proteus Biomedical, a specialist in digital health, said the United States Patent Office will award U.S. Patent Number 8,114,021 to Proteus. The patent, entitled “Body Associated Receiver and Method,” is directed to the Proteus wearable and ingestible sensor
technologies and related sensor devices used to create digital communication networks within, on and around the human body for health-related and other applications.

Proteus makes digital health products that collect and aggregate various behavioral, physiologic and therapeutic metrics – such as medication adherence, heart rate, sleep patterns, physical activity and stress levels – into meaningful and appropriate personal management tools delivered to the mobile devices of consumers. Proteus recently reported the commercial launch of two product systems in 2012 based on its product platform – a remote body monitoring system called Metria by its partner Avery Dennison, and a digital health product for family care givers called Helius with its partner Lloydspharmacy. The company says both product systems represent leading examples of an emerging industry of digital health products in which sensor-enabled devices associated with the body continuously monitor and deliver personalized information to individuals.

This patent is the 41st issued patent granted to the company. Proteus has more than fi ve hundred patents on digital health technologies and their uses pending or issued in the US and other countries.

“This patent describes devices worn on the body that communicate with other sensor-enabled devices in an optimal frequency band for body area communication networks,” said Mark Zdeblick, chief technical officer at Proteus. “This bandwidth and the principle of body area communication are ideal for low power, relatively low bit rate communications for digital health products.”

A Medical Device Daily Staff Report